ALS drug trial yields positive data: US study
Dexpramipexole, initially developed by Knopp Biosciences, is a novel drug which prevents dysfunction of mitochondria, the subcellular structures that provide most of a cell’s energy. The researchers devised
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.